YD Bio Limited (YDES)

YD Bio Statistics

Total Valuation

YD Bio has a market cap or net worth of $1.10 billion. The enterprise value is $1.09 billion.

Market Cap	1.10B
Enterprise Value	1.09B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

YD Bio has 70.32 million shares outstanding.

Current Share Class	70.32M
Shares Outstanding	70.32M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	34,769.25
Forward PS	n/a
PB Ratio	3.34
P/TBV Ratio	518.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	34,682.91
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.82, with a Debt / Equity ratio of 0.01.

Current Ratio	2.82
Quick Ratio	2.80
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-3.68%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-6,523
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	0.04
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	141,505

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, YD Bio had revenue of $31,500 and -$166,814 in losses. Loss per share was -$0.16.

Revenue	31,500
Gross Profit	-8,910
Operating Income	-181,165
Pretax Income	n/a
Net Income	-166,814
EBITDA	-178,945
EBIT	-181,165
Loss Per Share	-$0.16

Balance Sheet

The company has $2.77 million in cash and $54,077 in debt, giving a net cash position of $2.72 million or $0.04 per share.

Cash & Cash Equivalents	2.77M
Total Debt	54,077
Net Cash	2.72M
Net Cash Per Share	$0.04
Equity (Book Value)	4.91M
Book Value Per Share	4.67
Working Capital	2.01M

Cash Flow

Operating Cash Flow	-211,155
Capital Expenditures	-52,837
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	-28.29%
Operating Margin	-575.13%
Pretax Margin	-550.28%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

YD Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-0.02%
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

YD Bio has an Altman Z-Score of 26.3.

Altman Z-Score	26.3
Piotroski F-Score	n/a